AR065602A1 - Polimorfos de s , s dioxido del acido 7 - ( (3 - cloro-6 , 11 - dihidro-6-metildibenzo ( c , f ) (1 , 2 ) tiazepin- 11- il) amino ) heptanoico y metodos para su preparacion y uso - Google Patents

Polimorfos de s , s dioxido del acido 7 - ( (3 - cloro-6 , 11 - dihidro-6-metildibenzo ( c , f ) (1 , 2 ) tiazepin- 11- il) amino ) heptanoico y metodos para su preparacion y uso

Info

Publication number
AR065602A1
AR065602A1 ARP080100908A ARP080100908A AR065602A1 AR 065602 A1 AR065602 A1 AR 065602A1 AR P080100908 A ARP080100908 A AR P080100908A AR P080100908 A ARP080100908 A AR P080100908A AR 065602 A1 AR065602 A1 AR 065602A1
Authority
AR
Argentina
Prior art keywords
dihydro
amino
heptanoic
dioxide
acid
Prior art date
Application number
ARP080100908A
Other languages
English (en)
Original Assignee
Transform Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=39738742&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AR065602(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Transform Pharmaceuticals Inc filed Critical Transform Pharmaceuticals Inc
Publication of AR065602A1 publication Critical patent/AR065602A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D281/00—Heterocyclic compounds containing rings of more than six members having one nitrogen atom and one sulfur atom as the only ring hetero atoms
    • C07D281/02—Seven-membered rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Pulmonology (AREA)
  • Psychology (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)

Abstract

En la presente solicitud se revelan polimorfos de S,S-dioxido del ácido 7-[(3-cloro-6,11-dihidro-6-metildibenzo[c,f][1,2]tiazepin-11-iI)amino]heptanoico. También se describen aquí composiciones farmacéuticas que comprenden uno o varios polimorfos deS,S-dioxido ácido 7-[(3-cloro-6,11-dihidro-6-metildibenzo[c,f][1,2]tiazepin-11-il)amino]heptanoico, métodos para su preparacion, y métodos de tratamiento relacionados. Reivindicacion 2: La Forma 1 de S,S-dioxido del ácido 7-[(3-cloro-6,11-dihidro-6-metildibenzo[c,f][1,2]tiazepin-11-il)amino]heptanoico de la reivindicacion 1, donde dicha Forma 1 exhibe un difractograma de rayos X en polvo que comprende un pico a 2-theta aproximadamente 5,89 grados. Reivindicacion 11: La Forma 2 deS,S-dioxido del ácido 7-[(3-cloro-6,11-dihidro-6- metildibenzo[c,f][1,2]tiazepin-11-il)amino]heptanoico de la reivindicacion 10, donde dicha Forma 2 exhibe un difractograma de rayos X en polvo que comprende un pico a 2-theta aproximadamente 8,52grados.
ARP080100908A 2007-03-05 2008-03-05 Polimorfos de s , s dioxido del acido 7 - ( (3 - cloro-6 , 11 - dihidro-6-metildibenzo ( c , f ) (1 , 2 ) tiazepin- 11- il) amino ) heptanoico y metodos para su preparacion y uso AR065602A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US89294707P 2007-03-05 2007-03-05

Publications (1)

Publication Number Publication Date
AR065602A1 true AR065602A1 (es) 2009-06-17

Family

ID=39738742

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP080100908A AR065602A1 (es) 2007-03-05 2008-03-05 Polimorfos de s , s dioxido del acido 7 - ( (3 - cloro-6 , 11 - dihidro-6-metildibenzo ( c , f ) (1 , 2 ) tiazepin- 11- il) amino ) heptanoico y metodos para su preparacion y uso

Country Status (11)

Country Link
US (1) US8367656B2 (es)
EP (1) EP2137157A4 (es)
JP (1) JP2010520298A (es)
AR (1) AR065602A1 (es)
CA (1) CA2679936C (es)
CL (1) CL2008000653A1 (es)
JO (1) JO3046B1 (es)
PE (2) PE20090534A1 (es)
TW (1) TWI436988B (es)
UY (1) UY30952A1 (es)
WO (1) WO2008109577A1 (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8198268B2 (en) * 2008-10-31 2012-06-12 Janssen Biotech, Inc. Tianeptine sulfate salt forms and methods of making and using the same
US10624902B1 (en) 2017-08-08 2020-04-21 James Peter Morrissette Dietary supplement
CN111448195A (zh) * 2017-09-27 2020-07-24 费多拉制药公司 二氮杂二环辛烷衍生物的晶型及其生产方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3758528A (en) 1970-03-13 1973-09-11 Science Union & Cie Tricyclic compounds
JPS535661B2 (es) * 1972-03-07 1978-03-01
CA995213A (fr) 1972-03-16 1976-08-17 Charles Malen Procede de preparation de derives tricycliques
FR2594827B1 (fr) * 1986-02-21 1988-05-20 Adir Nouveau derive tricyclique denomme acide ((chloro-3 methyl-6 dioxo-5,5 dihydro-6, 11 dibenzo (c,f) thiazepine (1,2) yl-11 amino)-5 pentazoique, son procede de preparation et les compositions pharmaceutiques qui le contiennent
FR2716623B1 (fr) * 1994-02-25 1996-08-23 Adir Utilisation d'un dérivé tricyclique pour l'obtention de médicaments destinés au traitement des troubles mnémo-cognitifs.
GB9624615D0 (en) * 1996-11-26 1997-01-15 Zeneca Ltd Chrystallisation process
DE60001054T2 (de) * 1999-02-04 2003-07-24 Wyeth, Madison Trizyclische pyridin n-oxide vasopressin agonisten
DK1409101T3 (da) * 2001-05-05 2006-07-31 Accentus Plc Dannelse af små krystaller
US6683072B1 (en) * 2003-02-04 2004-01-27 Vela Pharmaceuticals, Inc. Compositions and methods for treatment of irritable bowel syndrome and nonulcer dyspepsia

Also Published As

Publication number Publication date
CL2008000653A1 (es) 2008-10-24
EP2137157A1 (en) 2009-12-30
UY30952A1 (es) 2008-09-30
PE20090534A1 (es) 2009-05-03
US8367656B2 (en) 2013-02-05
EP2137157A4 (en) 2010-12-15
CA2679936C (en) 2017-07-11
PE20120574A1 (es) 2012-05-23
JO3046B1 (ar) 2016-09-05
TW200846331A (en) 2008-12-01
US20080221081A1 (en) 2008-09-11
CA2679936A1 (en) 2008-09-12
JP2010520298A (ja) 2010-06-10
TWI436988B (zh) 2014-05-11
WO2008109577A1 (en) 2008-09-12

Similar Documents

Publication Publication Date Title
CL2009000349A1 (es) Compuestos derivados de 4,5-dihidro-oxazol-2-ilamina; procedimiento de preparacion; composicion farmaceutica; y su uso para el tratamiento de la enfermedad de alzheimer.
NZ596579A (en) Bace inhibitors
CL2012000163A1 (es) Compuestos derivados de quinazolina o pirido[2,3-d]pirimidina, inhibidores de la autofagia; composicion farmaceutica; y su uso para el tratamiento del cancer, pancreatitis, neurodegeneracion, entre otras.
ECSP099044A (es) Compuestos de pirimido fusionados
CL2007001283A1 (es) Compuestos derivados de pirazinona
CL2007000806A1 (es) Compuestos derivados de heteropentaciclos sustituidos; proceso de preparacion; compuestos intermediarios; composicion farmaceutica; y uso en el tratamiento del cancer.
MX2011007424A (es) Derivados de sulfonamida.
GEP201606555B (en) Compounds and compositions for modulating egfr activity
TW200801003A (en) Novel compounds
AR065247A1 (es) Sal de napadisilato y/o heminapadisilato de 5-(2-{[6-(2,2-difluoro-2-feniletoxi)hexil]amino]-1-hidroxietil)-8-hidroxiquinolin-2(1h)-ona,composiciones farmaceuticas que las contienen y usos en el tratamiento del asma y otras enfermedades pulmonares.
GEP20156366B (en) Iminothiadiazine dioxide compounds as bace inhibitors, compositions, and their use
BRPI0915084B8 (pt) composto, e, composição farmacêutica
MX2011011661A (es) Compuestos 1-cianoetilheterociclilcarboxamida sustituidos 750.
TW200745040A (en) Quinoline derivatives
BR112012016797A2 (pt) intensificador dinâmico de baixo utilizando compressor com equalizador incorporado
UA103319C2 (en) Thiazole- and oxazole-benzene sulfonamide compounds
AR058098A1 (es) Derivados de acidos dicarboxilicos y su uso
CL2007003765A1 (es) Compuestos derivados de 2-oxo-4-hidroxi-benzotiazol; procesode preparacion; composicion farmaceutica; combinacion farmaceutica; y uso en el tratamiento de enfermedades tales como epoc, bronquitis, asma y bronquiectasias.
TW200716529A (en) New compounds II
CL2008002689A1 (es) Compuestos derivados de heterociclo 1,4 piperidina sustituida; compuestos intermediarios; composicion farmaceutica; proceso de preparacion; y su uso en el tratamiento del alzheimer y esquizofrenia.
GEP201706656B (en) 2-thiopyrimidinones
CL2007001838A1 (es) Compuestos derivados de 4-oxoquinolina; composicion farmaceutica; y uso del compuesto para la produccion de un agente anti-vih.
WO2007097981A3 (en) Alpha carbolines and uses thereof
GEP20135959B (en) Aryl piperazine and their usage as alpha2c antagonists
MX2012005225A (es) Compuestos y composiciones de purina n-7 sustituida y pirazolopirimidina, y metodos de uso.

Legal Events

Date Code Title Description
FB Suspension of granting procedure